October 23, 2019  |  

Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery.

Authors: Bolukbasi, Mehmet Fatih and Gupta, Ankit and Wolfe, Scot A

The simplicity of site-specific genome targeting by type II clustered, regularly interspaced, short palindromic repeat (CRISPR)-Cas9 nucleases, along with their robust activity profile, has changed the landscape of genome editing. These favorable properties have made the CRISPR-Cas9 system the technology of choice for sequence-specific modifications in vertebrate systems. For many applications, whether the focus is on basic science investigations or therapeutic efficacy, activity and precision are important considerations when one is choosing a nuclease platform, target site and delivery method. Here we review recent methods for increasing the activity and accuracy of Cas9 and assessing the extent of off-target cleavage events.

Journal: Nature methods
DOI: 10.1038/nmeth.3684
Year: 2015

Read publication

Talk with an expert

If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.